Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2017 1
2019 3
2020 5
2021 1
2022 3
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Body weight regulation via MT1-MMP-mediated cleavage of GFRAL.
Chow CFW, Guo X, Asthana P, Zhang S, Wong SKK, Fallah S, Che S, Gurung S, Wang Z, Lee KB, Ge X, Yuan S, Xu H, Ip JPK, Jiang Z, Zhai L, Wu J, Zhang Y, Mahato AK, Saarma M, Lin CY, Kwan HY, Huang T, Lyu A, Zhou Z, Bian ZX, Wong HLX. Chow CFW, et al. Among authors: mahato ak. Nat Metab. 2022 Feb;4(2):203-212. doi: 10.1038/s42255-022-00529-5. Epub 2022 Feb 17. Nat Metab. 2022. PMID: 35177851
Adult-onset Still's Disease: A Case Report.
Karki B, K C N, Mahato AK, Kandel S, Acharya P. Karki B, et al. Among authors: mahato ak. JNMA J Nepal Med Assoc. 2023 Aug 1;61(264):662-664. doi: 10.31729/jnma.8237. JNMA J Nepal Med Assoc. 2023. PMID: 38289815 Free PMC article.
Novel RET agonist for the treatment of experimental neuropathies.
Viisanen H, Nuotio U, Kambur O, Mahato AK, Jokinen V, Lilius T, Li W, Santos HA, Karelson M, Rauhala P, Kalso E, Sidorova YA. Viisanen H, et al. Among authors: mahato ak. Mol Pain. 2020 Jan-Dec;16:1744806920950866. doi: 10.1177/1744806920950866. Mol Pain. 2020. PMID: 32811276 Free PMC article.
Biological Activity In Vitro, Absorption, BBB Penetration, and Tolerability of Nanoformulation of BT44:RET Agonist with Disease-Modifying Potential for the Treatment of Neurodegeneration.
Haider MS, Mahato AK, Kotliarova A, Forster S, Böttcher B, Stahlhut P, Sidorova Y, Luxenhofer R. Haider MS, et al. Among authors: mahato ak. Biomacromolecules. 2023 Oct 9;24(10):4348-4365. doi: 10.1021/acs.biomac.2c00761. Epub 2022 Oct 11. Biomacromolecules. 2023. PMID: 36219820 Free PMC article.
17 results